Friday, January 5, 2018


FDA aims to strengthen oversight of compounded drug manufacturing
The Food and Drug Administration aims to "reinvigorate" efforts to improve production standards for compounded drug products, highlighting continued safety concerns with the industry practice in a recent update published in the New England Journal of Medicine. Since a deadly meningitis outbreak in .
Post a Comment